» Articles » PMID: 34135271

A Diastolic Dysfunction Model in Non-human Primates with Transverse Aortic Constriction

Overview
Journal Exp Anim
Date 2021 Jun 17
PMID 34135271
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Transverse aortic constriction (TAC) has been widely used to study cardiac hypertrophy, fibrosis, diastolic dysfunction, and heart failure in rodents. Few studies have been reported in preclinical animal models. The similar physiology and anatomy between non-human primates (NHPs) and humans make NHPs valuable models for disease modeling and testing of drugs and devices. In the current study, we aimed to establish a TAC model in NHPs and characterize the structural and functional profiles of the heart after TAC. A non-absorbable suture was placed around the aorta between the brachiocephalic artery and left common carotid artery to create TAC. NHPs were divided into 2 groups according to pressure gradient (PG): the Mild Group (PG=31.01 ± 12.40 mmHg, n=3) and the Moderate Group (PG=53.00 ± 9.37 mmHg, n=4). At 4 weeks after TAC, animals in both TAC groups developed cardiac hypertrophy: enlarged myocytes and increased wall thickness of the left ventricular (LV) anterior wall. Although both TAC groups had normal systolic function that was similar to a Sham Group, the Moderate Group showed diastolic dysfunction that was associated with more severe cardiac fibrosis, as evidenced by a reduced A wave velocity, large E wave velocity/A wave velocity ratio, and short isovolumic relaxation time corrected by heart rate. Furthermore, no LV arrhythmia was observed in either animal group after TAC. A diastolic dysfunction model with cardiac hypertrophy and fibrosis was successfully developed in NHPs.

Citing Articles

Echocardiographic characterization of age- and sex-associated differences in cardiac function and morphometry in nonhuman primates.

Florio M, Fusini L, Tamborini G, Morrell C, McDonald A, Walcott M Geroscience. 2024; 46(5):4615-4634.

PMID: 38689157 PMC: 11335998. DOI: 10.1007/s11357-024-01172-6.


Large animal models to study effectiveness of therapy devices in the treatment of heart failure with preserved ejection fraction (HFpEF).

Fisher S, Murally A, Rajabally Z, Almas T, Azhar M, Cheema F Heart Fail Rev. 2023; 29(1):257-276.

PMID: 37999821 DOI: 10.1007/s10741-023-10371-w.


Imaging characterization of myocardial function, fibrosis, and perfusion in a nonhuman primate model with heart failure-like features.

Liu X, Wang G, Rui M, Fan D, Zhang J, Zhu Z Front Cardiovasc Med. 2023; 10:1214249.

PMID: 37663419 PMC: 10471131. DOI: 10.3389/fcvm.2023.1214249.

References
1.
Rockman H, Wachhorst S, Mao L, ROSS Jr J . ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. Am J Physiol. 1994; 266(6 Pt 2):H2468-75. DOI: 10.1152/ajpheart.1994.266.6.H2468. View

2.
Ye L, Zhang P, Duval S, Su L, Xiong Q, Zhang J . Thymosin β4 increases the potency of transplanted mesenchymal stem cells for myocardial repair. Circulation. 2013; 128(11 Suppl 1):S32-41. PMC: 3886821. DOI: 10.1161/CIRCULATIONAHA.112.000025. View

3.
Su L, Kong X, Lim S, Loo S, Tan S, Poh K . The prostaglandin H2 analog U-46619 improves the differentiation efficiency of human induced pluripotent stem cells into endothelial cells by activating both p38MAPK and ERK1/2 signaling pathways. Stem Cell Res Ther. 2018; 9(1):313. PMC: 6238266. DOI: 10.1186/s13287-018-1061-4. View

4.
Ponikowski P, Voors A, Anker S, Bueno H, Cleland J, Coats A . 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special.... Eur Heart J. 2016; 37(27):2129-2200. DOI: 10.1093/eurheartj/ehw128. View

5.
Ye L, DAgostino G, Loo S, Wang C, Su L, Tan S . Early Regenerative Capacity in the Porcine Heart. Circulation. 2018; 138(24):2798-2808. DOI: 10.1161/CIRCULATIONAHA.117.031542. View